Viewing Study NCT01240967


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2025-12-25 @ 10:47 PM
Study NCT ID: NCT01240967
Status: COMPLETED
Last Update Posted: 2014-03-17
First Post: 2010-11-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module